Cervical Cancer
Conditions
Brief summary
To detect the expression of AUNIP in cervical cancer serum, and to clarify its diagnostic and prognostic value.
Detailed description
Blood of all study participants of cervical cancer patients are collected to detect the expression of AUNIP, analyze the statistical correlation between the expression of cervical cancer AUNIP and clinicopathological parameters of patients, and preliminarily understand the expression of AUNIP in cervical cancer tumor tissues and its clinical diagnostic and progniostic value.
Interventions
DIAGNOSTIC_TESTDetection of serum AUNIP expression
The experiment is carried out according to the ELISA kit instructions, and the absorbance optic density (OD) value of the enzyme labeler at 450 nm is read. The protein concentration of AUNIP in the serum sample is calculated according to the standard curve.
Sponsors
Lin Yuan
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
20 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
Study group inclusion criteria: * Women aged 20-60 * There is a definite pathological diagnosis of cervical cancer Healthy control group: * Women aged 20-60 * No tumors in the uterus or other parts of the body * No inflammatory disease * Blood routine and blood biochemical tests are normal
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| AUNIP expression in serum | through study completion, an average of 3 year | Serum AUNIP expression is detected by ELISA kit. The results will be recorded seperately. |
Contacts
Primary ContactLin Yuan, Ph.D.
Outcome results
None listed